Biochemical and Biophysical Research Communications, Vol.531, No.3, 372-376, 2020
On the use of Europium (Eu) for designing new metal-based anticancer drugs
Europium oxide (Eu2O3) was used to evaluate the affinity of this rare earth element for interacting with double-stranded (ds) DNA molecules. To perform the study, we used single molecule force spectroscopy with optical tweezers and gel electrophoresis assays. Force spectroscopy experiments show that Eu2O3 presents a strong interaction with dsDNA, and the binding is independent on the ionic strength used the surrounding environment. Among the main characteristics of the interaction, Eu2O3 tends to bind a cooperative way, forming bound clusters of similar to 3 molecules, and presents a high equilibrium association binding constant on the order of 10(5) M-1. In addition, gel electrophoresis confirm the weak electrostatic character of the interaction and explicit show that Eu2O3 does not interfere on drug intercalation into the double-helix. Such results demonstrate the potential of europium for interacting with nucleic acids and strongly suggest that this rare earth element may be considered for the design of new metal-based anticancer drugs in the future. (c) 2020 Elsevier Inc. All rights reserved.